BioSpace News Archive

CooperCompanies, will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021.

MedAvail to Present at the Cowen 41 st Annual Health Care Conference

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the commencement of a proposed underwritten public offering of its shares of common stock. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount of up to 15% of the nu

Quidel Corporation (NASDAQ: QDEL) , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended December 31, 2020.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), today announced the closing of its previously announced public offering of 44,200,000 shares of its common stock at a public offering price of $2.00 per share, for gross proceeds of $88,400,000, before deducting underwriting discounts and offering expenses. After deducting underwriting fees and other offering expenses payable by the Company, the net proceeds to the Company were approximately $82.1 million.

Government of Canada officials will hold a media technical briefing on data and modelling informing public health action on coronavirus disease.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 431,600 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on March 10, 2021, and will hold a conference call to discuss the results on March 10, 2021 at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 43755

Nektar Therapeutics will announce its financial results for the fourth quarter and year-ended December 31, 2020, on Thursday, February 25, 2021, after the close of U.S.-based financial markets.

Agilent Technologies Inc. has earned the number two position on Barron’s annual list of America’s Most Sustainable Companies.